BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 20848588)

  • 1. Therapeutic potential of activators and inhibitors of sirtuins.
    Balcerczyk A; Pirola L
    Biofactors; 2010; 36(5):383-93. PubMed ID: 20848588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirtuin inhibitors.
    Alcaín FJ; Villalba JM
    Expert Opin Ther Pat; 2009 Mar; 19(3):283-94. PubMed ID: 19441904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirtuin-targeting drugs: Mechanisms of action and potential therapeutic applications.
    Aljada A; Dong L; Mousa SA
    Curr Opin Investig Drugs; 2010 Oct; 11(10):1158-68. PubMed ID: 20872319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. After the grape rush: sirtuins as epigenetic drug targets in neurodegenerative disorders.
    Huber K; Superti-Furga G
    Bioorg Med Chem; 2011 Jun; 19(12):3616-24. PubMed ID: 21306906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirtuin activators.
    Alcaín FJ; Villalba JM
    Expert Opin Ther Pat; 2009 Apr; 19(4):403-14. PubMed ID: 19441923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NAD(+) -dependent histone deacetylases (sirtuins) as novel therapeutic targets.
    Schemies J; Uciechowska U; Sippl W; Jung M
    Med Res Rev; 2010 Nov; 30(6):861-89. PubMed ID: 19824050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirtuin functions and modulation: from chemistry to the clinic.
    Carafa V; Rotili D; Forgione M; Cuomo F; Serretiello E; Hailu GS; Jarho E; Lahtela-Kakkonen M; Mai A; Altucci L
    Clin Epigenetics; 2016; 8():61. PubMed ID: 27226812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of NAD+ dependent histone deacetylases (sirtuins).
    Neugebauer RC; Sippl W; Jung M
    Curr Pharm Des; 2008; 14(6):562-73. PubMed ID: 18336301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirtuin modulators: an updated patent review (2012 - 2014).
    Mellini P; Valente S; Mai A
    Expert Opin Ther Pat; 2015 Jan; 25(1):5-15. PubMed ID: 25435179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neurobiology of sirtuins and their role in neurodegeneration.
    Donmez G
    Trends Pharmacol Sci; 2012 Sep; 33(9):494-501. PubMed ID: 22749331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule regulation of Sir2 protein deacetylases.
    Grubisha O; Smith BC; Denu JM
    FEBS J; 2005 Sep; 272(18):4607-16. PubMed ID: 16156783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIRTUIN 1: regulating the regulator.
    Zschoernig B; Mahlknecht U
    Biochem Biophys Res Commun; 2008 Nov; 376(2):251-5. PubMed ID: 18774777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism-based modulator discovery for sirtuin-catalyzed deacetylation reaction.
    Zheng W
    Mini Rev Med Chem; 2013 Jan; 13(1):132-54. PubMed ID: 22876953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of 1,4-dihydropyridine structural scaffold: discovery of novel sirtuin activators and inhibitors.
    Mai A; Valente S; Meade S; Carafa V; Tardugno M; Nebbioso A; Galmozzi A; Mitro N; De Fabiani E; Altucci L; Kazantsev A
    J Med Chem; 2009 Sep; 52(17):5496-504. PubMed ID: 19663498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New assays and approaches for discovery and design of Sirtuin modulators.
    Schutkowski M; Fischer F; Roessler C; Steegborn C
    Expert Opin Drug Discov; 2014 Feb; 9(2):183-99. PubMed ID: 24382304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect.
    Lara E; Mai A; Calvanese V; Altucci L; Lopez-Nieva P; Martinez-Chantar ML; Varela-Rey M; Rotili D; Nebbioso A; Ropero S; Montoya G; Oyarzabal J; Velasco S; Serrano M; Witt M; Villar-Garea A; Imhof A; Mato JM; Esteller M; Fraga MF
    Oncogene; 2009 Feb; 28(6):781-91. PubMed ID: 19060927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Function and regulation of the mitochondrial sirtuin isoform Sirt5 in Mammalia.
    Gertz M; Steegborn C
    Biochim Biophys Acta; 2010 Aug; 1804(8):1658-65. PubMed ID: 19766741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirtuin mechanism and inhibition: explored with N(ε)-acetyl-lysine analogs.
    Hirsch BM; Zheng W
    Mol Biosyst; 2011 Jan; 7(1):16-28. PubMed ID: 20842312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of sirtuin-activating compounds in Alzheimer's disease.
    Gan L
    Drug News Perspect; 2007 May; 20(4):233-9. PubMed ID: 17637936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirtuin 1 (SIRT1): the misunderstood HDAC.
    Stünkel W; Campbell RM
    J Biomol Screen; 2011 Dec; 16(10):1153-69. PubMed ID: 22086720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.